ÆȒɀȳ»õü€½Ȱ
ǎŊďƛł¦Ņʖ
ȢȰ±ǯȫÖÈ
+/$*%6('.*%A
.+ //+.,.0)*0+ %0.%/*6)*
7(+,)*0>%.0+.J,/K*0. +.
(%*#*(+4*#%/+../
%$%#*00*%7./%0:
U
ōŊǿ
•  ɱɐʆʉʇɋʃɲʀʆɩńȾƛTńǷŸŃ¿ɇ
aȼȣşȋȰďƛł¦ŅȰúńĴȰưƴ
•  ƒ¨ŅijȫƭìîĝȰŔư
•  ƀ½Ȓɀȳ›€ȰǎŊďƛł¦ŅȰ
ĜŇȮǧȞȩȉ?ĻȞȐɃơBȾĜŇîĝȰ
ƵƲǿǿ
V
ȬȐȞȩIJȮ€½ɇXɂșɃȰȓ?
•  €½ȰǔŅƛTńȱŝȪȎɃʊʊȞȓȞȉȌ9ƛŅijȰȎɃ$
kžȍȱŝȪȱȭȏA
•  €½ȱĿ½ȫ^ċȮȰ9ƛ½Ń¿Ȱ[Ƈ½ȔȎɃ
•  €½Ȕ9ƛ½Ń¿ȪȎȦȣu]ȱȉĎȰɀȐȭǧȮlǩȫ9
Ȑ@
I  ĚùȰùű
I  ġĹ
I  9Ĺ
•  ÇȋȱLŇžȫ¿žUîȮȉ¿žȰĸĠȰƺɇæhȟɃȣȼȰ
ÊĘȔȎɃȚȫɇőɁȠɃ¹ƤȔȎɃʑ
•  ÇȋȱljRVT§ȮȒȏȩ€½Ȱďƛł¦ȮǟȞȩŠɈȪȕȣʑ
€½ȫďƛł¦ǿ
()">
•  ùűlj|Ȱ€½ȰŭUVʨWTʌȱȉƄ÷Ȯďƛł¦ȔȎɃA
•  ùűlǩȾùűlj|ȮÀȻ2ȩȰ§ǾžȰ€½ȱȉ’ªȾŗĸĠȮ
ȒȏȩlǩɇÑȑȩȏɃʑ
•  #?CE-3%.
@
6D' @,?&E
B<$;@F*9;4EA
•  ũnňŚƱĆ@ùűlj|Ȱ€½ȰȪďƛł¦ŅȔNȼɃC
]ȱʙ
ƱƧ
»õüǿ
ĸė[Ƈ§Ǿǿ
ů
VTTV
UZ`
X`
W`
VTUV
[[`
W]`
%((:0(AA+)*/(0$M*./AVTTV?UU@W]
X
L
ùűlj|Ȯ•Ȟȩ\ĈĆɇƜȦȣL¤ȰC]
UTT
]T
\T
[T
ZT
YT
XT
WT
VT
UT
T
+:),.06.
ħĨŽ
(%*#%)
9ƛöǞ
ƛĶťŽ
M
‰4“ǤR
*+)0.%(%+,/:
‰4ƏĸĈ
:/0.+/+,:
‰ǚĈĆ
ùűƫǙ
*/0.6(%.:
‰DZǐŮƆƭ
,/).
ĽijƍČƇĈĆ
$:.+%
ƻǮĞĈĆ
(0./+6*
Y
ũnùűlj|ɇ\ńkȫƥȭȞȣL¤
ȰC]ǿʍjŤé&"!jVĴ %ʎǿ
L¤ȰC]
Percent Physicians
80
70
60
50
40
30
20
10
0
%((:0(AA+)*/(0$M*./AVTTV?UU@W]
ȈȈȈȈȈƓ¢ľcȰC]ʍʌʎȈȈȈȈȈ
òÿȮȒȘɃƓ¢ľcȮɀɃùűŅijʍjŤébV[Xʎ
ǿ
ǿ
0
%
1
#
3
!
+
.
4
.
)
*
,
$
%
'
-
%
2
(
&
ljRWȓùȮˆŚYƭȞȣ{ā¿žʍV[XʎȰùűŅijȰƓ¢ľc
*'0(A
*0.*1+*(+6.*(+ +)*B/$(0$AVTUX@Z
€½ȫŵ9ƛȮǟDžȞȩ
•  Ł$)ČǟJK@:‡µ9ƛȱĹˆĕȰøȽȣɃQkȪȎɃ
JŁȰ2ŅȰUEXK
•  ȱŁȪU\TTȰ€½Ȕùűlj|ȫ܎ȞȩȏɃU
•  UTGUY`Ȱ€½ȱĸģȰȐȥȪùűlj|űǸȔȎɃV
•  ùűlj|ȱˆŚLȶȰůȰʒʕʌɇNȼȉWTȔ‰ã9ƝɇYȘ
9ƛ
V
ȩȏɃ
ɧʊɡȭȞ
TATUGUTATT`
•  ç¼ǐȮùűlj|ȪâǀȜɄɃ›€ȰZȮUȔɱɐʆʉʇɋʃɲʀʆɩń
UTATUGVTATT`
VTATUGWTATT`
ȪȎɃW
eWTATU`
•  ̧VTTȰUYēȰ›€Ȕ9ĹȞȩȏɃX
>).#*:,.0)*0?
>+.((0$.#*%;1+*
UA)%0$A .$.)VTUW?\T@UZG\?VA)/)"4)0+(+#:)+)0+(6
.+#.)VTTZ?X[XG\Y?WA).%*):+ %0.%/+))%3+*+(/*>).%*
+((#+ /00.%%*/*:*+(+#%/0/+))%3+*+(/*0(0$.A%0.%/
$*A*0VTTZ?WZ[@UTZZG[XA
VTTZ?UU\@VVXYGYT?XA$3,@EE888A8$+A%*0E)%*0.E
0/$0/E /WZXE*EA
ȭȡ»õüȰďƛł¦ɇőɃ¹ƤȔȎɃȰȓʙ
•  ǂnȪȱȉĚòVT>TTTȰU\ēȰ›€Ȕ9Ĺ
ȞȩȏɃȊ
•  [T>TTTȰ›€Ȕ†ʉ9ĹöȰ]ŅȪĕȞȩ
ȏɃȊȢȰȮȱ:‡µ9ƛȮɀɃȽȰȽȎɃȤɅȐȊǿ
•  WVTȔ2Ȫȭȏų8źɇYȘȩȒɂȉďƛł
¦ȔȎɃȫ9ƛȰOǥȱw}ȟɃȊǿ
ē
ē
ē
*%01+*/+,6(1+*6*,+.0VTUWA
€½ďƛł¦@sŕǿ
•  |ǕȰùű9ƛJ+.*+..$#%K@
– 
– 
– 
– 
– 
[òǞȰÕŴ
Ŏ´VAYʦʧȰ7ƛv
ɱɎʁɣʆ(
UöǞțȫȮɡʆɷʆʉɪɳɓʆȰßȔ¹Ƥ
ùűțȫȮ\T)(Ȱ9ƛ
•  :‡µ9ƛ@űƊ:‡ȪȱYTT)(ȉ£ĵ;ǝȪ
ȱUTTT)(Ȱ9ƛǿ
–  ʒĎ½:‡µ9ƛ@:‡µVXöǞ4ʑUTTT)(ȱǔŅ
–  VĎ½:‡µ9ƛ@:‡µVXöǞȓɁUVdž
)/4/$" $%'))VTT]?WZ@UYW?A+))%3,%*%+*+AWX]A/$%"<::@2;:B3;=<=?$%(%,,>0(A
<:;;2<:>3<:CA+#$%.+>0(AVTUT?\@VTZWA
LV6,/bYTT)(
UT
|ǕȰùű9ƛȰ§Ǿ>Qk
+6.0/:)/*
Qk
»õüįÙP½9ƛ
ďƛł¦
ÉŊgǵ
íȣȭ2ƼŃ¿
Î7mŇĝ
Ɲµ]Ņ
ĽijƍČƇŅ
ǜűüįÙP½9ƛ
UWFU] VTFWX WYFX]
ē
ē
ē
YT
ē
ǎ½ďƛł¦ŅȰşǷ
ɱɐʆʉʇɋʃɲʀʆɩń
ƛšĂČƇł¦Ņ
ƛTń$kž
ƛTńǷŸŃ¿
–  ɱɋɲʁɬʊɗʆ>7mŢȁk‰ȉȃk‰ȉ
Ȅk‰ȉȇk‰ȉȇȀk‰ȉȇȂk‰
–  Ƣ]7mk‰č
•  ȢȰ
–  ǎ½9ƛ½þćƛŦÓ¯Ņ
–  ɏʊʀɝʉɢʆʄɝŅ'Ż
• 
• 
• 
• 
888A#++#(A+)
UV
€½ƛTńʉƛTń$kžȰIJ½
•  ƛTń$kžȱ€½ȪȎɃȰȪȉȧȰzłȰȎ
ɃąƕɇȽȦȩȏɃU
ƛTńǎ‰ɇ$úȞȩȏɃ€½Ȱ
•  ĊDŽ@ʀɌɑɫɟʊɛɿʆ>ǔɴɦʄÛ]>qƟ
ȭąƕĠJ>ɡʊɪʊŅ'ŻʍKU>V
Ȕ
•  ライオニゼーションにより、不規則に染色体の
U本が遺伝子発現を抑える構造に変化し、血友病
保因者のⅧ因子やⅨ因子を著しく低下させるこ
とがあるW
Y
9ƛŅijɇưȼȩȏɃ
•  ƛTń$kžȱ9ƛŅijȔįȏȫúɃȔȎɃU
–  k‰Ġ½ȔY`ȓɁXT`Ȱ$kžȱ9ƛŅijȔ
ƥɁɄɃȚȫȔȎɂȉƽŅƛTńȫȏȑɃU
–  k‰Ġ½ȔXT`ȓɁZT`ȽȎɃȪȽ9ƛɇűǸ
ȟɃu]ȔȎɃX
UA 
VA 
> 0+.
A
WA 
XA 
YA 
ZA 
+.(.1+*+ )+,$%(%A..%./*+)*%0$)+,$%(%AVTUVA
+.0/0(A)+,$%(%*)+,$%(%A
*@6/$*/':0(A/A "" #(#)%"%/A\0$A8+.'>@.8%((?
VTUT@VTT]FVTV]A
6/.F6*/$+0*A+.(.1+*+ )+,$%(%A:),0+)1..%./+ )+,$%(%AVTT\A
(6#
0(A"%%AVTTZ?UT\@YVFYZA
)+,$%(%.1+*+ ).%A$3,@EE888A$)+,$%(% A+.#E(%*#F%/+../E*F8+)*F$7F(%*#F%/+../AVTUYA//.6.:
W>VTUYA
$3,@EE888A/++,A%0E0E)+(:0E,EV]WXZTUYVEVTUUET[EUXEYTF:./F+ F0$F(:+*F$:,+0$/%/F*F9F%*171+*F0F0$F6.+,*F:0+#*1%/0/F
//+%1+*FF+* .*F,+.0+
# of patients
ƛTńA$kžȰȅk‰Ġ½
$kž
)¦ž
Factor
VIII Levels (%)
ȅk‰Ġ½
Kasper, et al
(%:.A..+*'(
$kžȮȫȦȩȰxȫȫȹȬȏǿ
•  $kžȫȱǎŠŊdŜȪȎȦȩȉ
ƒ¨ƭìȪȱȭ
ȭȏU
•  |ȗȰLŇžȱ$kžȔ9ƛɇȟ
ɃȫȏȐȚȫɇ:ȓȦȩȏȭȏA
•  9ƛöȮȱȉ¾‰Ⱦ/­Ȱ7m
k‰ơBɇġĻȞȩȏɃ$kžȽ
ȏɃ
•  ȌƛTńȍȫȏȐƭì_Ȕ)«$ǥ
Ȱ?Ļɇ[ƇȮȞȣɂȉIÔLŇ
ȶȰNJɇǝȗU>V
UA 
VA 
(.%#A)8.A$3,@EE888A$)8.A+.#E/0+.:E..%.F..%.A6(%/$6(:VTUVA//
.6.:W>VTUYA
*
*A$3,@EE6*%,.0*./A*0E!(/E
]A, A7%/6*VTUWA//.6.:]>VTUYA
ƛTń$kžFC$)+,$%(%/=D
• 
• 
• 
ŔŽ$kž
–  ƛTńȰıɇÕȧ2ȩȰ…
–  ƛTń¿žɇÕȥȉ’Ŭ4Ȯ›ȭȗȫȽȰƛTń¿ž
ʍ/­ȉŘıȉWıȉĺȉȏȫȚʎȔȏɃęƧ
–  VȰƛTń¿žɇÕȧęƧ
܎$kž
–  $kžȰ2ȩȰ…
–  UȰƛTń¿žɇÕȧȔȉƛŸȮƛTń¿žȽ$kžȽ
ȏȭȏęƧ
–  $kžȰƒ‚ȉęƧȉęîŘęȉWęȉ„ȉ¶ƒ‚
ƽŅƛTńJZT`KȫȏȑɃk‰Ġ½Ȱ$kžȱ9ƛ+`
ȔȎɃȓȽȞɄȭȏ
+:(+((1+*.6/0
6*%0+.%
6*%0+.%>.%*(.0>+,+(>
%0+.%(%>0.%
6/.F6*/$+0*A.0)*0+ )+,$%(%.%/6).XZAVTT\A
ƛTńȰǎ
$kžȪȎɃęƧȓɁȰǎǿǿ
+0$.
0$.
+*
ƛTńȪȎɃıƧȓɁȰǎ
+*
6#$0.6#$0.
)¦
+0$.
0$.
+*
+*
ƛTń
+8((0(A
*@..0(>/A $)'%5(" $ "#)%"%/4UW0$A$%((,$%>@%,,%*+3%((%)/M%('%*/?VTUX@UUXWFUU\[A
6#$0. 6#$0.
$kž
ȰȣȼȮȉȏȧ$kžȰȣȼȮĈĆɇƜȐȓ
ȭȡ$kžĈĆɇȟɃȓ
•  9ƛɇǠȞȉ¹ƤȭďƛÝźɇȫɃU
•  ‰‹ȶȰĬoŊʁɝɔȰưƴV
•  ĸėȮǟȟɃǍÐƁȰÞ W
•  nj;ȭĜŇȾŦķȰÞ U
š0üȪȰĈĆȰ?ĮU
• óüȰèƂ
ȏȧƜȐȓȮȱƵƲȰpȎɂU>W
• §ǾȾūřŊ±ǯȉêJŊ%ĀɇŽ
ÅȞȭȘɄȲȭɁȭȏ1
• 9ƛŅijȰȎɃȮǟȞȩȱ»õü
AȮĈĆɇYȘɃȷȕU
óüĈĆȰčĮU
• ‰
ȰƓ™¸ȮÁ±ǯȓ
• ĈĆȶȰɝɨʃɝȔšȜȏ
• |ȗȰ$kžȔóüɇǍÐȞȩȏɃ
• ‰
Ȱ’ðȶȰưƴȮđȺ
• ‰
Ȯ=ìɇȿȤȯɁɄȭȏ
• ƛTńĜŇɞʆɡʊȾ)«$ǥȶ
ȰʼnǙ
• ’ðǟ#ȶȰÁ±ǯ
>$)+,$%(%0.0)*0*0.A
UA  *%*)+,$%(%+%0:A$3,@EE888A$)+,$%(%AE*E(%*#F%/+../E$)+,$%(%FF*FE$.%0:F+ F$)+,$%(%EQU[UAVTUYA
VA  +.(.1+*+ )+,$%(%A..%./*+)*%0$)+,$%(%AVTUVA
WA  $+)/0(A#%& " 4VTT[?UW@ZWWFZXUA
$kžȰ9ƛǿ
UA 
C]
ùűlǩǿ
VTFYT`
ŵ9ƛ
VVFXW`
ǫȎȝ
U]FZ[`
Ɲµ
V\FZU`
ǽ9ƛ
\FXW`
ZƉ49ƛǿ
UVF[[`
ǟŧ49ƛ
\`
ƾƛ
U[FVU`
$.0$'6).0(A#%& " AVTT]?UY@]UFUTTAVA%/$0(A#%& " A
VTUU?U[@VXZFVYUAWA(6#
0(A"%%AVTTZ?UT\@YVFYZAAPA6/.6*/$+0*0(A'%#
#%()AU]\\?Y]JWK@WX]FWYVA
U]
$kžȰ9ƛ@ƛŸƛTń¿žȰ
ǔŅ©Ⱦǎ‰złȫǟDžǿ
9ƛ+`ȫǎ‰zł
• 
$kž
• 
%/$Ɂȱǎ‰złȰ=ôȞȩȏ
ɃXZȰ$kžɇŒŠȞȣǿǿ
UTT`
ɌʆɨʄʆVVǁȰ$kžȱɹɝɞʆɝz
łȮěȷȩȉ@
\T`
–  ƧðȰƛTń¿žȱǔŅȔ|ȏǿ
ZT`
–  ȅk‰Ġ½Ȕȏ
–  9ƛȔ|ȏ
+*/*/
)601+*
(1+*
*0.+*VV
%//*/
)601+*
XT`
VT`
T`
0.+*#
' °ȏ
+
9ƛ+`
®ȏ
ȭȞ
9ƛ+` (%*#
9ƛ+`
(%*# (%*#
J*bUUK
UA 
%/$0(A#%& " AVTUU?U[@VXZFVYUA
J*bUWK
J*bU\K
ǎɒɍʆɞʁʆɕ
•  ǎɒɍʆɞʀʊȱIÔLŇɣʊɺȰ
fȪȭȘɄȲȭɁȭȏ
•  ďƛł¦€½ȱɯʊɨɪʊȫȫȽȮǎ
ɒɍʆɞʁʆɕɇYȘȭȘɄȲȭɁȭȏ
– 
– 
– 
– 
Ń¿ȰǎȮǟȞȩ
$kžƭìȰǍÐƁȮǟȞȩ
9ĸAƭìȮǟȞȩ
×0îĝȰǍÐƁȮǟȞȩ
•  ɒɍʆɞʁʆɕȱŒśȜɄȉŹŮȪȉł
êJȶȰķƩɇɆȭȘɄȲȭɁȭȏ
•  IÔLŇɣʊɺȮɀɃÂŶŊʉ¸ķŊà
FȔÞ ȜɄȭȘɄȲȭɁȭȏǿ
$3,@EE888A/(%/$.A*0E#0$'.UXWE#*1F+6*/((%*#F[).$UW.#+6.7
VU
ɱɐʆʉʇɋʃɲʀʆɩńJK
•  øȽƔŊȭďƛł¦Ņ
•  ŋƎŪƏȰ9ƛȔIJ·ʍǽ9ƛȉĢJŦ9ƛȉùűlj|ʎ
•  ɱɐʆʉʇɋʃɲʀʆɩk‰(VWF)ȰƺŊł¦ȎɃȏȱǕŊĦ›ȮɀɃ
•  |ȗȱ¦ąƕ.½ȪȉȹɄȮµ~½ȔȎɃʑ2ȩȰşȮSȵʑ
•  ńr.
•  Type 1
70%
•  Type 2
15-20%
•  Type 3
5-10 %
VV
NHLBIʍnš¸ƃƛĤŒŠÉʎ:
ɱɐʆʉʇɋʃɲʀʆɩńȰ9ƛ
ùűlj|
ǽ9ƛ
ÏĒµ9ƛ
9ƛë
;ɂ*ȉäɂ*µȰ9ƛ
Ēƀ9ƛ
ǟŧ49ƛ
ĢJŦ9ƛ
WV`FUTT`
W\`FZV`
V\`FYV`
X]`FYV`
WZ`
VZ`FWY`
VT`FV\`
UX`
4 $%( (1-",*%$1$$#$)%-%$ ""'$ ((?VTT\A
VW
婦人科的問題に関する
フォン・ヴィレブランド病（VWD）と健常者の比較U
Éƥ
ùűlj|
P¡ȰȐƆ
‰4ƏŅ
‰ţƋ
‰4ƏwėŅ
ɷʁʊɳ
‰ã9Ɲ
;4 ')-1)"4#%& " <::=2C3<C<7<CA
ʥ
*bUTV
)¦ž
*b\\
7(6
]Y`
YV`
WT`
WV`
UT`
\`
VZ`
ZU`
VV`
UW`
U[`
U`
U`
]`
cTATU
cTATTTU
TATTY
TATV
TATU
TATX
cTATU
VX
月経過多の成人/思春期女性の疾患別割合
;4 
<4 
=4 
>4 
?4 
Ń¿
Æ
»õü
ɱɐʆʉʇɋʃɲʀʆɩń
YFVT`
5-36%
ƛšĂČƇł¦Ņ
cUFYT`
2-44%
7m
k‰č
Ņ
cUFX`
<1-4%
ƛTń$kž
cUFX`
8%
ƛTńǷŸŃ¿
cU`
ƛšĂĦ›Ņǿ13-20%
ýƭì
17%
'1)"$);CCB2<:;=
',(1)"4'%#$#%()<::;
""/1)"4())$/$%"<::;
%%1)"4"%%%," ' $%"/( (4<::<
/( $)"4<::@
?4%%#$7',$1)"4%#$9(")$(
<::;
@4",$)"4##)%"4;CC@2?=3<=>
A4#(1)"4#())/$%"4<::>2;C;3>>C
B4 " &&)"4<::=1<::?
C4 ""()"4#%& " 4<:;=
VY
ňŚÉƥ
VZ
婦人科的徴候と症状:
止血異常
•  ¼½ł¦‰9ƛʍʎɇaȻ
ùűlj|JXZF[V`K
•  ÙPö9ƛ
•  9ƛ½P¡ȰȐƆ
– 
– 
– 
– 
– 
– 
ɱɐʆʉʇɋʃɲʀʆɩńJZA\`K
ƛTń$kž
ɱɋɲʁɬɗʆč
Ņ
7m
>k‰č
Ņ
7m
k‰č
ŅJVT`K
ƛšĂǨ‘
$3:>VTUX?JVK:*>VTT[?'>VTTW?
JWK+0/$%>U]]Z?+-6>VTTX?JXK)/>VTTY?JYK$.:>VTUW?*JZK)/>VTUX
V[
ǿ‰4ƏŅǿ>‰4ƏwėŅǿ>ɷʁʊɳȫ
Fallopian tube
Ovary
‰ţƋ
Uterus
Endomet
implants
Uterosacral
ligament
Endomet
implants
Rectum
Bladder
$'#(4,!$ -'( )/111
V\